Identification of targeted membrane antigens of human brain microvascular endothelial cells in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Takeshita, Y. [1 ]
Fujikawa, S. [1 ]
Nishihara, H. [2 ]
Maeda, T. [1 ]
Shimizu, F. [1 ]
Sano, Y. [1 ]
Koga, M. [1 ]
Kanda, T. [1 ]
机构：
[1] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi, Japan
[2] Univ Bern, Theodor Kocher Inst, Bern, Switzerland
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2019年 / 405卷
关键词：
D O I：
10.1016/j.jns.2019.10.821
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
WCN19-0438
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Relapsing-remitting multiple sclerosis and subclinical atherosclerosis
    Omerzu, T.
    Magdic, J.
    Hojs, R.
    Fabjan, T. Hojs
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 376 - 377
  • [32] Identification of markers of relapse in a relapsing-remitting mouse model of multiple sclerosis
    Chase, Carol Ann
    Forsthuber, Thomas
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [33] Treating relapsing-remitting multiple sclerosis: therapy effects on brain atrophy
    Vidal-Jordana, Angela
    Sastre-Garriga, Jaume
    Rovira, Alex
    Montalban, Xavier
    JOURNAL OF NEUROLOGY, 2015, 262 (12) : 2617 - 2626
  • [34] Effect of intravenous methylprednisolone on brain atrophy in relapsing-remitting multiple sclerosis
    Zivadinov, R
    Rudick, RA
    De Masi, R
    Nasuelli, D
    Ukmar, M
    Pozzi-Mucelli, RS
    Grop, A
    Cazzato, G
    Zorzon, M
    NEUROLOGY, 2001, 56 (08) : A192 - A192
  • [35] An update on cladribine for relapsing-remitting multiple sclerosis
    Holmoy, Trygve
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1627 - 1635
  • [36] Therapeutic inertia in relapsing-remitting multiple sclerosis
    Rodrigues, Rita
    Rocha, Raquel
    Bonifacio, Goncalo
    Ferro, Daniela
    Sabenca, Francisco
    Goncalves, Ana Isabel
    Correia, Filipe
    Pinheiro, Joaquim
    Loureiro, Jose Leal
    Guerreiro, Rui Pedro
    Vale, Jose
    Sa, Maria Jose
    Costa, Andreia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 55
  • [37] A CASE OF RELAPSING-REMITTING TUMEFACTIVE MULTIPLE SCLEROSIS
    Turnbull, H.
    Karsan, N.
    Hogg, F.
    Pereira, A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83
  • [38] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
  • [39] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [40] Development of laquinimod for relapsing-remitting multiple sclerosis
    Jeffery, Douglas R.
    FUTURE NEUROLOGY, 2008, 3 (06) : 641 - 648
12345